Clinical Trial Update: Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial investigating targeting ischemia-induced autophagy dependence in hepatocellular carcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: VA Office of Research and Development | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: RECRUITING